Table 1. Inhibition Data of the Compounds SH7a–t and the Standard Sulfonamide Inhibitor Acetazolamide (AAZ) towards Human CA I, II, IX and XII, as Determined by Using a Stopped-Flow CO2 Hydrase Assay18.
Cpd. | R | R1 |
KI (nM)a |
|||
---|---|---|---|---|---|---|
hCA I | hCA II | hCA IX | hCA XII | |||
SH7a | H | H | 51,420 | 61.3 | 33.4 | 42.5 |
SH7b | H | 4-F | 48,070 | 34.5 | 26.1 | 51.3 |
SH7c | H | 4-Cl | 57,520 | 65.8 | 39.8 | 59.6 |
SH7d | H | 4-OCH3 | 54,180 | 37.6 | 44.5 | 22.2 |
SH7e | H | 4-COOEt | 63,810 | 46.2 | 63.2 | 27.5 |
SH7f | H | 4-SO2NH2 | 791.7 | 54.7 | 24.3 | 39.3 |
SH7g | H | thiazol-2-yl | 60,790 | 72.4 | 67.6 | 30.4 |
SH7h | H | 4-NO2 | 52,270 | 38.1 | 37.4 | 49.7 |
SH7i | OCH3 | H | 73,810 | 96.9 | 34.9 | 35.9 |
SH7j | OCH3 | 4-F | 69,580 | 87.3 | 22.1 | 43.4 |
SH7k | OCH3 | 4-Cl | 81,340 | 123.4 | 17.4 | 48.8 |
SH7l | OCH3 | 4-OCH3 | 76,460 | 103.7 | 41.3 | 16.7 |
SH7m | OCH3 | 4-COOEt | 72,770 | 93.5 | 55.7 | 26.9 |
SH7n | OCH3 | 4-SO2NH2 | 837.8 | 59.3 | 32.4 | 32.6 |
SH7o | OCH3 | thiazol-2-yl | 89,140 | 131.2 | 35.1 | 24.3 |
SH7p | OCH3 | 4-Br | 85,390 | 157.1 | 19.3 | 57.1 |
SH7q | OCH3 | 4-Br,2-F | 83,060 | 126.3 | 16.2 | 65.7 |
SH7r | OCH3 | 3-CF3 | 77,690 | 81.5 | 23.5 | 52.4 |
SH7s | OCH3 | 4-Cl,3-CF3 | 80,350 | 114.6 | 15.9 | 55.2 |
SH7t | OCH3 | 4-OCF3 | 74,170 | 86.3 | 29.6 | 19.0 |
AAZ | 250.0 | 12.5 | 26.0 | 5.7 |
Mean from three independent assays, measured by using a stopped-flow technique (errors were in the range of ±5–10% of the reported values).